Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
2006 Standout
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
2008
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Access to pain treatment as a human right
2010
Hallmarks of Cancer: The Next Generation
2011 Standout
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
EGFR and cancer prognosis
2001 Standout
Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein
1993
MRP and MDR1 gene expression in primary breast carcinomas.
1996
Patterns of metastatic breast carcinoma: influence of tumour histological grade
2004
Prognostic factors for patients with hepatic metastases from breast cancer
2003
Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional Significance
1997
Prevalence of Depression in Patients With Cancer
2004 Standout
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
2014 StandoutNobel
An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors
1993
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
2001
QuPath: Open source software for digital pathology image analysis
2017 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *
1996
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy
1995
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
2011 Standout
Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for ‘well-tolerated’ treatments?
2001
Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors
2000
Prognostic factors in early breast carcinoma
1994
The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers
1999
Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer
1996
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
The impact of patient and public involvement on UK NHS health care: a systematic review
2011
Bone metastases from breast carcinoma: histopathological – radiological correlations and prognostic features
2003
The Basic Pathology of Human Breast Cancer
2000
Mechanisms of resistance to antiangiogenesis therapy
2010
Serum Tumor Markers in Breast Cancer: Are They of Clinical Value?
2006
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Targeting multidrug resistance in cancer
2006 Standout
Pathological prognostic factors in breast cancer
1999 Standout
The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy
2001
Biological factors of prognostic significance in locally advanced breast cancer
1994
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research
2017 Standout
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancer
1995
Mucins in the pathogenesis of breast cancer: Implications in diagnosis, prognosis and therapy
2011
Recombinant human VEGF165b protein is an effective anti-cancer agent in mice
2008
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Information needs across the colorectal cancer care continuum: scoping the literature
2012
Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy
1994
The greater impact of menopause on ER– than ER+ breast cancer incidence: a possible explanation (United States)
2002
The Ki-67 protein: From the known and the unknown
2000 Standout
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples
1995
The Human Plasma Proteome
2002 Standout
Tumour marker measurements in the diagnosis and monitoring of breast cancer
2000
Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Depression and anxiety in women with early breast cancer: five year observational cohort study
2005 Standout
Programmed Translational Readthrough Generates Antiangiogenic VEGF-Ax
2014
The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy
2014
Alternative transcription and alternative splicing in cancer
2012
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
2006
Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations
2005
Breast cancer metastasis: markers and models
2005 Standout
Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol-based ligand-binding assays
1996
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)*
2001
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival
1995
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
2012 Standout
Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study
2000
The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.
1993
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
2003 Standout
Multidrug resistance in human tumors—molecular diagnosis and clinical significance
1999
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
2017 Standout
Serum CA 15.3, CEA and ESR Patterns in Breast Cancer
1997
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?
2009
Different Gene Expression Patterns in Invasive Lobular and Ductal Carcinomas of the Breast
2004
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
The Simian Immunodeficiency Virus ΔnefVaccine, after Application to the Tonsils of Rhesus Macaques, Replicates Primarily within CD4+T Cells and Elicits a Local Perforin-Positive CD8+T-Cell Response
2002 StandoutNobel
Works of AR Dixon being referenced
P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy
1992
Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy
1992
A randomised trial of second-line hormone vs single agent chemotherapy in tamoxifen resistant advanced breast cancer
1992
Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?
1993
A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast
1991
VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
2008
Hormone sensitivity in breast cancer: Influence of heterogeneity of oestrogen receptor expression and cell proliferation
1991
Methodology of immunohistological detection of oestrogen receptor in human breast carcinoma in formalin‐fixed, paraffin‐embedded tissue: a comparison with frozen section methodology
1993
Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer – a comparison with CA15.3
1993
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival
1990
Phyllodes tumours of the breast: a clinicopathological review of thirty‐two cases
1995
Cervical intraepithelial neoplasia and squamous cell carcinoma of the anus in sexually active women
1991
Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment
1992
Evaluation of the IMMULITE BR-MA and CEA assays and comparison with immunoradiometric assays for CA15-3 and CEA in breast cancer.
1997
A Colorectal Cancer Patient Focus Group Develops an Information Package
2006
Continuous cytotoxics in responsive metastatic breast cancer: A role for tumour markers
1992